Kenalog 40

Kenalog 40: properties, use, contraindications and side effects

Kenalog 40 is a drug belonging to the pharmacological group of glucocorticosteroids, which is used to treat various diseases. The active substance is triamcinolone, which has powerful anti-inflammatory and immunosuppressive properties.

The drug is manufactured by several companies, including Berlin-Chemie AG from Germany, Bristol-Myers Squibb from Italy, and Krka dd from Slovenia. The injection suspension contains 40 mg/ml triamcinolone.

Kenalog 40 is used for adrenal insufficiency, autoimmune thyroiditis, hypercalcemia in malignant neoplasms, psoriatic arthritis, gouty and rheumatoid arthritis, ankylosing spondylitis, bursitis, tendovaginitis, post-traumatic osteoarthritis, epicondylitis, systemic lupus erythematosus, rheumatic carditis, pemphigus, Stevens-Johnson syndrome, many erythema formis , dermatitis (exfoliative, herpetiform, bullous, seborrheic, contact, atonic), psoriasis, allergic rhinitis, bronchial asthma, serum or drug sickness, allergic conjunctivitis, keratitis, iridocyclitis, sarcoidosis, Loeffler's syndrome, borreliosis, aspiration pneumonia, idiopathic thrombocytopenic adult purpura , secondary thrombocytopenia in adults, anemia (autoimmune hemolytic, hereditary hypoplastic), erythroblastopenia, acute or chronic lymphoblastic leukemia, lymphogranulomatosis, non-Hodgkin's lymphomas, breast cancer, prostate cancer, myeloma, tuberculous meningitis, acute lymphocytic leukemia in children, nephrotic syndrome, nonspecific Eskom ulcerative colitis, Crohn's disease, celiac disease and hyperthermia in malignant neoplasms.

However, Kenalog 40 has contraindications, including hypersensitivity, systemic mycoses, glaucoma, gastric and duodenal ulcers,